95% of our viewers aren’t subscribed. If you’re watching and not yet subscribed, please subscribe to the channel so you don’t miss future episodes.

How do leading CDMOs move beyond scale to become true strategic partners?

This week on Making It In Manufacturing, Harry Sloan sat down with John Gagliardi, Sales Director, Key Account Management at Samsung Biologics, with 25+ years of experience spanning operations, supply chain, procurement, sourcing and commercial leadership across biopharma, including previous experience at GSK and leadership in CDMO partnerships.

In this episode, John Gagliardi covers:

- How Samsung Biologics has evolved as a pure-play CDMO, including US expansion and the value of integrated support from clinical development through commercial supply.

- Why long-term partnerships in biomanufacturing depend on value creation beyond capacity, from lifecycle management to flexible supply chain strategies.

- What credible ADC capability really looks like, including integrated manufacturing, simplified supply chains and how co-located operations can accelerate speed to market.

- The strategic importance of the Lilly Gateway Labs collaboration with Eli Lilly, and how incubating early-stage biotech can strengthen the future innovation ecosystem.

- Where growth is heading next for Samsung Biologics, from Bio Campus expansion and emerging modalities to scaling quality while maintaining operational agility.

If you are interested in where biomanufacturing partnerships are heading, and how leading CDMOs are thinking beyond capacity alone, this conversation offers practical insight worth your time.

Watch the full episode to hear how John approaches growth, innovation and patient impact through a commercial and operational lens.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr

TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com/

Youtube: https://www.youtube.com/@artotalent

John Gagliardi

Sales Director at Samsung Biologics

LinkedIn: https://www.linkedin.com/in/john-gagliardi-7a8a252/

Harry Sloan

CDMO BD Lead at ARTO

LinkedIn: linkedin.com/in/harry-sloan-605620154/?lipi=urn%3Ali%3Apage%3Ad_flagship3_profile_view_base%3B7ieBaX%2FATH6lSPMIPdsI8w%3D%3D

Timestamps:

00:00 Introduction from New York and conference spotlight

00:42 Samsung Biologics as a pure-play CDMO

02:10 Building strategic customer partnerships

03:45 Differentiation beyond standard CDMO models

05:01 Building credibility in ADC manufacturing

07:53 Technical collaboration and winning partnerships

09:07 Lilly Gateway Labs collaboration

11:40 Growth trajectory and future modalities

13:19 Scaling while maintaining quality

15:00 Patient impact and personal motivation

16:35 Closing remarks

#MakingItInManufacturing #ARTOTalent #Biomanufacturing #CDMO #Biopharma #SupplyChain #ADC #PharmaceuticalManufacturing #BiotechLeadership

Hosted on Acast. See acast.com/privacy for more information.